Trial Profile
A non-interventional,multicentre,observational study to evaluate the therapeutic benefits of insulin glargine with NPH insulin in diabetic patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Apr 2017
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 10 Mar 2017 New trial record